ASCO23 - Cleveland Clinic

Tag debug info: client: {"assets":{},"datasets":{},"live":{},"projects":{},"users":{},"observable":{"assets":{},"datasets":{},"live":{},"projects":{},"users":{}}}
Now: 1770452525860
Cache Key: cqdTagPageBySlug:asco23
fetchCache[cqdTagPageBySlug:asco23].expirationTime: falsey
fetchCache[cqdTagPageBySlug:asco23]. seconds remaining: falsey
All fetchCache expiration times:
-- Key: cqdNotFoundPage, seconds remaining: 2472
-- Key: cqdTagPageBySlug:first-voices, seconds remaining: 2472
-- Key: cqdPostsByTag:cqd-migrated-tag-21896,1,10, seconds remaining: 2622
-- Key: cqdTagPageBySlug:left-ventricular-systolic-dysfunction, seconds remaining: 4164
-- Key: cqdPostsByTag:cqd-migrated-tag-20284,1,10, seconds remaining: 4235
-- Key: cqdTagPageBySlug:steven-wexner, seconds remaining: 4804
-- Key: cqdPostsByTag:cqd-migrated-tag-1344,1,10, seconds remaining: 4874
-- Key: cqdTagPageBySlug:astrocytes, seconds remaining: 5248
-- Key: cqdPostsByTag:cqd-migrated-tag-26644,1,10, seconds remaining: 5312
-- Key: cqdTagPageBySlug:vorolanib, seconds remaining: 5514
-- Key: cqdPostsByTag:cqd-migrated-tag-25054,1,10, seconds remaining: 5597
-- Key: cqdTagPageBySlug:hypothyroidism, seconds remaining: 5928
-- Key: cqdPostsByTag:cqd-migrated-tag-14425,1,10, seconds remaining: 5991
-- Key: cqdTagPageBySlug:epilepsy-surgery, seconds remaining: 6392
-- Key: cqdPostsByTag:cqd-migrated-tag-1231,1,10, seconds remaining: 6459
-- Key: cqdTagPageBySlug:mortality-risk, seconds remaining: 6834
-- Key: cqdPostsByTag:cqd-migrated-tag-4812,1,10, seconds remaining: 6905
-- Key: cqdTagPageBySlug:afirma-gene-expression-classifier, seconds remaining: 9353
-- Key: cqdPostsByTag:cqd-migrated-tag-23037,1,10, seconds remaining: 9428
conditions:
-- false,
-- NA,
-- NA,
-- NA
-- false
Cache miss for key cqdTagPageBySlug:asco23 - retrieving from Sanity
CCCache.dataFetchCount: 1030
Cache cleanup seconds remaining: 22472

Tag: ASCO23

Enfortumab Plus Pembrolizumab May Represent New First-Line Standard in Advanced Urothelial Cancer

Luspatercept Shows Promise as Treatment for Anemia in Patients With Myelofibrosis

First-in-Class Bifunctional EGFR Inhibitor Shows Promising Activity in Metastatic Head and Neck Cancers, Especially When Given with Immunotherapy

Foundational Research Yields Clues to Understanding Early-Onset Colorectal Cancer